Global Director Medical Affairs, Biomarkers and Diagnostics @ Merck
Regional Director Medical Affairs, Biomarkers and Diagnostics, Japan @ Merck
Head of Immuno-Oncology Medical Affairs and MSL Manager, Medical Affairs, Japan @ Merck Group
Global Correlative Science leader-Japan and Group Manager, Correlative Science and CDx group, RA @ Novartis
Global Correlative Science Leader Japan @ Novartis
Manager, Early Strategic Planning Group, R and D @ AbbVie
JSPS Research Fellow (Postdoctoral Fellow and Graduate student at University of Tsukuba) @ University of Tsukuba
Masayuki Kanai's Education
Memorial Sloan Kettering Cancer Center
Research Associate (Senior PostDoc)
2013 - 2014
Moffitt Cancer Center
Research Scientist
2007 - 2013
University of Cincinnati
Research Scientist
2005 - 2007
Japan Society for the Promotion of Science (JSPS) at University of Tsukuba
JSPS Doctoral (DC1)/Postdoctoral (PD) fellow
2002 - 2005
University of Tsukuba
Doctor of Philosophy (PhD) (Medical Science)
2001 - 2004
University of Tsukuba
Master of Science (MS) (Medical Science)
1999 - 2001
Saitama University (埼玉大学)
Bachelor of Science (BS) (Biology)
1995 - 1999
Masayuki Kanai's Skills
Leadership
Immunoassays
qPCR
Cell Biology
Signal Transduction
Transfection
Western Blotting
In Vivo
Animal Models
Cell Signaling
Masayuki Kanai's Summary
Masayuki Kanai, based in United States, is currently a Vice President, Biomarkers and Companion Diagnostic Development at Taiho Oncology, Inc., bringing experience from previous roles at Daiichi Sankyo, Inc. and Merck. Masayuki Kanai holds a 2013 - 2014 Research Associate (Senior PostDoc) @ Memorial Sloan Kettering Cancer Center. With a robust skill set that includes Leadership, Immunoassays, qPCR, Cell Biology, Signal Transduction and more, Masayuki Kanai contributes valuable insights to the industry. Masayuki Kanai has 3 emails and 1 mobile phone number on RocketReach.